Company Filing History:
Years Active: 2001
Title: Janine T Bryan: Innovator in HPV Vaccine Development
Introduction
Janine T Bryan is a notable inventor based in the United States. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines for human papillomavirus (HPV). Her work focuses on optimizing the expression of HPV proteins in yeast, which is crucial for vaccine production.
Latest Patents
Janine T Bryan holds patents related to the optimized expression of HPV proteins. One of her latest patents is titled "Optimized Expression Of HPV 52 L1 In Yeast." This invention provides synthetic DNA molecules encoding the HPV 52 L1 protein, which are codon-optimized for high-level expression in yeast cells. The synthetic molecules can be utilized to produce HPV 52 virus-like particles (VLPs) and vaccines that offer effective immunoprophylaxis against papillomavirus infection. Another significant patent is "Optimized Expression Of HPV 45 L1 In Yeast," which similarly focuses on the HPV 45 L1 protein and its application in vaccine development.
Career Highlights
Janine T Bryan is currently associated with Merck Sharp & Dohme Corp., where she continues her research and development efforts in the field of vaccines. Her innovative work has the potential to impact public health significantly by providing effective treatments and preventive measures against HPV infections.
Collaborations
Throughout her career, Janine has collaborated with several professionals, including Michelle K Brownlow and Loren D Schultz. These collaborations have enhanced her research and contributed to the advancement of vaccine technology.
Conclusion
Janine T Bryan is a pioneering inventor whose work in HPV vaccine development is making strides in biotechnology. Her contributions are vital for the future of immunization against HPV, showcasing the importance of innovation in healthcare.